Infectious Diseases Completed Phase 3 Trials for Moxifloxacin (DB00218)

Also known as: Infectious Disease

IndicationStatusPhase
DBCOND0028267 (Infectious Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00828971A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIsTreatment